Barney Pell is an entrepreneur and VC. Barney Pell's Syndicate, Ecoation, Moon Express, Singularity U. Prev: Bing, Powerset, Mayfield, NASA, AI games pioneer.

San Francisco
Joined November 2008
My talk at Train AI 2017: Crucial Questions for Success of AI Applications. Video: goo.gl/iFdbdS, Slides: goo.gl/VNDMSE
9
9
5
66
Barney Pell retweeted
为什么现在的顶尖大模型说话越来越“拗口、难懂”了? NYU 和 UT Austin 刚刚发了一篇非常扎心的心理语言学论文,直接扒开了现代大模型“不好好说人话”的底牌。 研究人员把 Claude Sonnet 5 / Opus 5.5、GPT-5.6、GLM-5、Kimi K2.5 等 9 款前沿模型拉出来做全方位句法解剖,发现了 3 个反直觉真相: 1️⃣ 顶尖 AI 正在滥用 6 种“高认知负荷”句式 相比真实人类写作和同义回译文本,前沿模型极度偏爱:省略 that 的宾语从句、多重名词硬堆叠(如 reader-patience budget)、名词强行作动词(如 calendar it / footnote it)、无生命主语配动作动词,以及超长句法依存距离。这些特征在心理语言学里全是消耗人类短期记忆的“阅读杀手”。 2️⃣ 根源在于“人类大脑”与“推理后训练”的错位 人类语言遵循“均匀信息密度(UID)”——为了照顾听众有限的工作记忆,我们会本能地加入过渡词把信息摊平。而现代大模型经过大量数学、代码和推理(RLVR)后训练,只追求在有限窗口内最大化“信息密度”。 3️⃣ 一个简单的长度惩罚,就能复刻这种“反人类文风” 团队在微调实验中加入长度惩罚(Length Penalty),逼模型少用 Token,结果模型立刻学会了砍掉连接词、堆叠名词,瞬间变成那股熟悉的“高密度 AI 味”。 当模型为了解题效率疯狂压缩 Token 时,你觉得未来的 AI 应该区分“高密度推理模式”和“人类友好沟通模式”吗?
80
163
52
1,574
118,906
Barney Pell retweeted
Researchers simulated 22,689 ICU patients using LLMs They built a multi-agent LLM system where each AI agent simulates one organ system (heart, kidneys, immune, lungs...) and they coordinate in real-time like a real body. It’s called “Organ-Agents” And it'll completely change the way we test medical treatments. Instead of building one massive AI to guess what happens to a patient, researchers built 9 separate AI agents. Each agent plays the role of a specific human organ system. One AI is the cardiovascular system. One is the kidneys. One is the lungs. Then, they connected them all together into a simulated ecosystem using reinforcement learning. When they introduce a disease or a drug into the simulation, the "Heart Agent" reacts, which triggers a biological response in the "Kidney Agent," which forces the "Immune Agent" to adapt. The AI isn't just predicting an outcome. It is literally simulating the biological chain reaction of human physiology in real-time. They tested it on severe, high-acuity critical care patients. The digital twin remained perfectly stable and physiologically coherent. But here is the real breakthrough. Because it's built of separate communicating agents, clinicians can now run complex counterfactuals. They can pause the simulation, change a baseline condition, and instantly see the alternate timeline of "what would have happened if we gave this drug two hours earlier." We are moving away from testing hypotheses on real patients. We are moving toward a future where every person gets a perfectly synced digital twin. The hospital of the future won't just treat you. It will simulate your death a thousand times in the cloud, just to figure out the exact path to save you.
22
33
6
191
6,865
Barney Pell retweeted
When an LLM agent executes a long task, the hardest question is usually not whether it failed but where. Which step actually broke the run? 🧵 That’s the failure attribution problem, and it’s becoming central to debugging agentic systems. But current approaches have a real cost problem: 1. Prompting-based pipelines, where an LLM reads the whole trajectory and judges each step, are slow and expensive to run. 2. Post-trained attribution models need failure trajectories labeled at the step level, which are painful to collect and hard to scale. We think a practical failure attribution model should be lightweight and shouldn’t need step-level labels on failures at all. So in our #neurips2026 paper, “Tracing Agentic Failure from the Flow of Success,” we ask: can you find where an agent went wrong by learning only what going right looks like? Meet OAT 🌾 The idea: treat failure attribution as one-class learning. We train only on successful trajectories, using neural controlled differential equations to model how successful runs evolve in latent space. Think of it as learning the “flow” of a healthy agent trajectory. At inference, we take a failed trajectory and score every step by how far it drifts from those learned success dynamics. Steps that deviate most get flagged as the likely error steps. The algorithm doesn't rely on any step-level annotation. What we found: ⚡ With just 100 successful trajectories for training, OAT runs 200-5000× faster than prompting-based baselines (including GPT-5 judge). 📈 It also outperforms them on accuracy: about +20% F1 score. So you don’t have to trade cost for quality here. You can get both. Why I’m excited about this: successful runs are cheap and plentiful, while carefully annotated failures are not. Building diagnostics on top of the data we already have feels like the right direction as agent systems grow longer and more complex. Huge thanks to my amazing student @Samuel861025 for leading the effort, and collaborators from Microsoft Research @ShaleenDeep and Yiwen Zhu. 📄 Paper: arxiv.org/abs/2607.12747
29
46
6
259
13,310
Barney Pell retweeted
Scientists found a way to flush Alzheimer’s plaque out of the brain in minutes. Without any surgery and drugs. Your brain has a waste-clearance network called the glymphatic system. It flushes out toxic proteins and dead cells. But it only really activates during deep, slow-wave sleep. If you don't sleep, the trash piles up. Over time, that buildup leads to cognitive decline and Alzheimer's. Until today. Researchers just published a paper proving they can manually trigger this cleaning cycle. Without you ever going to sleep. They used 40.68 MHz ultrashort waves (USW) beamed non-invasively into the brain. Within 10 minutes, the brain's fluid flow rapidly accelerated. The waves artificially synchronized the neurons into a Delta state, the exact frequency of deep sleep. This forced the brain's water channels to open and start flushing out the system. They tested it on mice with traumatic brain injuries and Alzheimer's pathology. The brain swelling dropped. The toxic proteins were cleared out. Cognitive deficits actually improved. No surgery. No massive chemical interventions. Just a frequency.
603
7,688
789
32,074
1,453,742
Barney Pell retweeted
Just published @Nature A 3-agent AI personal health agent exceeded performance of a large language model/chatbot and serves as a foundation to build on for integrating sensor data, medical knowledge and coaching nature.com/articles/s41586-0…
37
117
17
576
54,145
Wow this is so exciting! A truly new window into the neural correlates of consciousness, and it makes so much more sense than prior theories.
3
467
Barney Pell retweeted
This paper is one of the coolest angles on Post-Training you will see. Researchers have spent a lot of time thinking about why language models struggle so much with genuine spatial and geometric common sense. The obvious culprit is that human web text is mostly cheap conversational shortcuts; it rarely forces a model to ground itself in strict, multi-dimensional physics. The authors asked a really clever question here: what if you use solved protein structures as a reasoning teacher? A single folded protein has thousands of mathematically rigid, verifiable topological facts baked in. They built a framework called Fold2Reason that trains the model on both structural Q&A and continuous 3D coordinate decoding. Naturally, it folds proteins way better than base Qwen3.5-9B, but what grabbed me was the transfer. When they tested it out-of-domain on 10 standard reasoning benchmarks, accuracy jumped across the board on spatial visualization, graph puzzles, scientific logic & even BBH. My immediate cynical reaction was "surely this is just generic post-training regularization noise," but their controls are what sold me. When they ran the same setup on random, synthetic, or shuffled structures, the gains completely evaporated. The model is actually feeding off the coherent physical logic of real biology. This makes a strong case for looking beyond human language when we want to teach models how to think systematically. Read the full paper here: arxiv.org/pdf/2609.38879
19
58
11
657
23,421
Barney Pell retweeted
By my count, China has cleared 160 novel drugs for first-in-human clinical trials this year — so far. One of them is a potential treatment for sepsis, a condition associated with ~20% of all deaths globally. The drug, made by Pyrotech Therapeutics, is the first to enter the clinic that blocks formation of the gasdermin D pore (that triggers pyroptosis - inflammatory cell death - in sepsis). That’s just one of many — we looked at all of them here: breakingground.substack.com/…
12
97
23
726
80,535
Barney Pell retweeted
Here's a cool new drug that just dosed its first patient in China. It targets the cancer antigen, B7-H3, and 'desialylates' - removes surface sialic acids that suppress immune responses. In experiments, this activates tumor killing, mainly by NK cells and macrophages. The trial is in China, run by Shanghai Henlius - the tech itself originated from the US biotech, Palleon Pharma. This desialylation mechanism is independent of PD1: in other words, a potentially new cancer immunotherapy.
By my count, China has cleared 160 novel drugs for first-in-human clinical trials this year — so far. One of them is a potential treatment for sepsis, a condition associated with ~20% of all deaths globally. The drug, made by Pyrotech Therapeutics, is the first to enter the clinic that blocks formation of the gasdermin D pore (that triggers pyroptosis - inflammatory cell death - in sepsis). That’s just one of many — we looked at all of them here: breakingground.substack.com/…
10
72
6
368
19,012
Barney Pell retweeted
Scientists have sequenced the genomes of thousands of species. But for most of them, nobody knows *where the genes are* Today we're releasing Carbon-A, an open model that finds genes directly in DNA. We used it to create a database of 566 million candidate genes across 22,617 species, from fungi to mammals (that we are sharing as well) Why bother? A few reasons 1. Elephants rarely get cancer. Part of the explanation turned up in their genes: extra copies of a tumor-suppressor gene humans have only one of. You can't ask that kind of question about a species until someone, or some tool, has found its genes. 2. The first GLP-1 drug was based on a peptide from Gila monster venom. Nobody would have put the Gila monster on a priority list. Same for wild relatives of crops, which carry resistance to drought and disease. Many of these species have never been annotated. 3. Most of what we know about genes comes from about a dozen model species, like mice, flies and yeast. That focus worked remarkably well, but annotation pipelines still lean heavily on comparisons with them, which makes genes unique to other species easy to miss, and those can be the most interesting ones. Carbon-A belongs to a newer family of tools that read DNA directly. It learned from known genomes, but it doesn't need a close relative to read a new one. 4. Even familiar genomes still have gaps. With our partners at Active Site and UCSD, we found RNA evidence for 239 genes missing from the reference annotations of species as common as cats, chickens, hamsters and a lab plant. 5. AlphaFold can predict the shape of a protein, but only once someone has found the gene that makes it. In a species with no annotated genes, it has nothing to work with. Some notes on safety: Carbon-A doesn't design DNA or predict what a gene does. It marks where genes are in DNA. This is one of the reasons we think releasing it openly is the right call. More annotations also help health research: many species that carry or cause disease are among those covered, and work on controlling the diseases they spread often starts from their genes. Model and database and more details in Georgia's thread 👇
Today, we're releasing the Carbon Annotation Database and the model behind it, Carbon-A. We've used this model to discover 566.34 million new gene candidates across 22,617 species, thousands of which have never been studied like this before. We wet-lab validated a number of these new genes in well-studied species, such as in cats, chicken, and arabidopsis (plant), with our partners at Active Site and @UCSD, with more extensive wet lab results on previously-unstudied genomes coming soon.
18
33
5
227
16,439
Barney Pell retweeted
T-Mobile spent five years trying to get rid of the exact spectrum Elon just called "the last critical piece" of complete phone coverage in America. This 800 MHz block is Sprint's old Nextel spectrum, the stuff that powered push-to-talk walkie-talkie phones in 2004. The DOJ forced T-Mobile to divest it as a condition of the $26 billion Sprint merger. Dish had first rights at $3.59 billion and walked away because it couldn't raise the money. T-Mobile finally offloaded it to an investment firm called Grain Management last year for $2.9 billion plus a spectrum swap. Grain's original plan was selling it to utilities for private networks. Fourteen months later, SpaceX buys the whole portfolio, and shares of the carriers who passed on it fall as much as 8% in a single afternoon. Here's why it matters so much. Starlink's satellite signal at 2 GHz can reach your phone outdoors, but it dies at the first wall. 800 MHz penetrates buildings. Most phones already have the band built in. So satellites handle the open sky, this low-band layer handles indoors, and suddenly Starlink Mobile covers everywhere a normal carrier does without the tower network. Stack the moves. $17 billion for EchoStar's 50 MHz of 2 GHz spectrum. FCC approval for 15,000 Gen2 satellites this week. Now the low-band coverage layer. Verizon, AT&T, and T-Mobile paid $81 billion in a single auction for C-band spectrum in 2021, then spent years and tens of billions more deploying it on towers. SpaceX assembled a nationwide carrier out of a distressed-asset sale, a forced divestiture castoff, and rockets it already owns. The walkie-talkie spectrum from 2004 ended up being the piece that lets satellites replace cell towers. Nobody who touched it for twenty years saw that coming.
We announced an agreement to acquire a nationwide low-band spectrum license portfolio that will pave the way for @Starlink to become a major mobile carrier in the US. With this new spectrum and our Gen2 constellation, Starlink Mobile can ensure Americans have access to high-speed mobile broadband no matter where they are → spacex.com/updates#starlink-…
782
4,563
427
36,199
2,147,287
Barney Pell retweeted
Mad cow disease spreads when one misfolded protein forces others to copy its shape. A new Nature study shows tau, the protein behind Alzheimer's, does the same thing, even inside a mouse brain. Researchers at the MRC Laboratory of Molecular Biology in Cambridge, with collaborators in Japan, tested a central idea in neurodegeneration research: that different diseases are driven by different shapes of the same protein. Some background first. Tau is a protein that normally helps stabilize the internal scaffolding of neurons. In more than 20 brain diseases, including Alzheimer's disease and corticobasal degeneration (CBD, a rarer disorder affecting movement and thinking), tau misfolds and clumps into long fibers called filaments. Using a technique called cryo-EM, which images molecules at near-atomic detail, scientists found that each disease has its own filament shape, or fold. Alzheimer's has one. CBD has another. Prions, the cause of mad cow disease and Creutzfeldt-Jakob disease, work through templating. One misfolded protein acts as a mold, forcing normal copies of the protein to fold into the same shape. Different shapes are called strains, and each strain produces its own disease pattern. The open question was whether tau strains do the same thing. Do they keep their shape when they spread? Nobody had shown it. What the researchers did: • Extracted tau filaments from the brains of people with Alzheimer's or CBD • Injected them into the brains of normal, non-engineered mice • Waited 9 months, then examined the mouse brains and imaged the filaments that formed What they found: • The filaments that formed were made of the mouse's own tau, not the injected human tau • Their structures matched the human seeds. Alzheimer's seeds produced Alzheimer's-type filaments and CBD seeds produced CBD-type filaments • Pathology spread from the injection site to the cortex and other brain regions • Alzheimer's seeds caused tau pathology only in neurons • CBD seeds caused pathology in neurons and in glial cells (support cells), including plaque-like clusters in astrocytes, the same pattern seen in human CBD This matters because earlier mouse models, including genetically engineered ones, often produced filaments that didn't match human disease. Here, the shape was preserved from seed to copy, which is the defining feature of a prion strain. There are limits. The seeds were injected directly into the brain, which is not how disease begins in people. The study shows tau can template its shape. It does not show that Alzheimer's spreads from person to person. But it gives researchers a clean model for asking how a specific tau shape drives a specific disease, and for testing treatments aimed at stopping the copying. For longevity, the implications are conceptual, since the study didn't test any intervention. If tau pathology starts from a small seed and amplifies by templating, the early years matter most. A few practical takeaways: • Early detection: Blood biomarkers like p-tau217 and tau imaging that catch the process before it spreads become more valuable, especially if you have a family history • Training: Regular aerobic and resistance exercise is linked to lower dementia risk in human cohorts, and cardiorespiratory fitness is one of the stronger predictors. This study doesn't test exercise, but if the goal is to slow how fast seeds get amplified, keeping your brain's vascular and metabolic environment healthy is a reasonable place to start • Sleep: Poor sleep is associated with more tau accumulation in humans, so protecting sleep is part of the same strategy • Cellular cleanup: Systems like autophagy may matter most for clearing seeds early, rather than reversing pathology once it's established The exercise, sleep, and autophagy points are my inference, not something the study tested. The seed-and-amplify model suggests brain aging is decided slowly and early. The fitness, sleep, and metabolic health you build in your 30s, 40s, and 50s shapes how much tau pathology your brain has to deal with in your 70s and 80s.
2
8
1
43
2,035
Barney Pell retweeted
Out today: a new DeepMind Institute essay from James Manyika and @AlexOlegImas that explores how scientists are using AI models to accelerate science. These findings are based on usage data from 15M Gemini interactions, 2,600 specialised models, and 600+ surveyed researchers.
New essay for the @GoogleDeepMind Institute with James Manyika on AI x Science, "Bending the Curve of Discovery". While accelerating existing scientific practices is certainly useful, the real promise of AI is its potential to act as an invention of a method of invention (IMI) a la Griliches--e.g., the microscope or statistical inference--which would unlock questions and whole modes of discovery that were previously beyond human reach. Today, LLMs and specialized models like AlphaFold act as economic complements. LLMs handle analysis, coding, and writing, while specialized tools handle domain-specific predictions. Most handoffs between them run through the scientist. What may the future of science look like? LLMs orchestrating those handoffs automatically--prompting specialized models, auditing outputs, and looping until either the question is answered or a non-automated stage is reached (e.g., wet lab testing). The scientist's role shifts from running each step to designing this loop. We saw a glimpse of this workflow with Anthropic’s enzyme discovery a few weeks ago, and we're seeing this in our own work too. This raises foundational epistemic questions: 1. What will scientific understanding look like when discoveries are made by black-box models whose output is increasingly difficult to interpret? 2. How do we extract underlying mechanisms, not just outputs, as science becomes more automated? What will theory look like? 3. If AI automates the writing and junior lab work, how do we train the next generation of scientists to push the frontier? 4. What will motivate scientists in this epistemic reality? There's an economics angle too. Hypothesis generation gets cheap, so bottlenecks move downstream to verification and to choosing which questions are worth asking. Realizing AI’s full potential will take investment in infrastructure and institutional reform--making this as much an organizational challenge as a technical one We don't have the answers yet, and I'd love to hear what others think. Paper here: bit.ly/ai-in-science
10
21
1
157
10,170
Barney Pell retweeted
Working with AI models, I've arrived at what I consider the most significant pure-theory breakthrough of my research (in theoretical neuroscience) so far: arxiv.org/abs/2610.12426 Chaotic systems show what is colloquially called the butterfly effect, namely, a tiny nudge to the initial state grows exponentially in time. How fast the nudge grows depends on its direction. Each direction has its own growth rate, called a Lyapunov exponent, and the full set of rates is the Lyapunov spectrum. The Lyapunov spectrum is a rich (and diffeomorphism-invariant) characterization of chaos, telling us how many directions are chaotic, how many dimensions the attractor occupies, and how fast the dynamics generate information. In 1988, Sompolinsky, Crisanti, and Sommers (Physical Review Letters) introduced a nonlinear recurrent-network model of N randomly coupled neurons that becomes chaotic when the coupling strength exceeds a critical value. This network has since become a cornerstone of theoretical neuroscience, both as a model of the spontaneous activity of cortex and as the starting point for training recurrent networks on tasks. I have worked on this model for much of my research. In the same paper, the authors obtained the largest Lyapunov exponent from the ground-state energy of a Schrödinger equation and named the full Lyapunov spectrum as an open problem. In 2023, beautiful work by Engelken et al. (Physical Review Research) computed the full Lyapunov spectrum numerically. However, an analytical calculation of the full Lyapunov spectrum has remained out of reach. Four decades after the problem was posed, this paper derives the full Lyapunov spectrum at large N from a simple self-consistent single-site problem. This calculation has three steps. First, we lower every exponent by a constant s, which turns the question "how many exponents lie below s?" into the question "how many tangent directions decay?" We show that, if we drive the shifted tangent dynamics with a source and take the minimum-norm solution, the one-step response is the projector onto the decaying directions. Thus, the trace of this projector counts the decaying directions. This step is exact at finite N. Second, to work with the minimum-norm solution, we cast it as the vanishing-regularization limit of the solution of a least-squares problem. This regularized solution in turn solves a dynamical system with one field running forward in time and another running backward. Third, we apply the cavity method, that is, we add one neuron to the network, along with its forward and backward fields. The effect of the rest of the network on this neuron then reduces to the classical dynamical mean-field description of the activity of this neuron, plus two kernels that couple the forward and backward fields of this neuron to each other across time. Thus, the full Lyapunov spectrum follows from a single-site problem, which boils down to the self-consistent calculation of these kernels. The resulting theory agrees closely with simulations for the Lyapunov spectrum, the attractor dimension, and the entropy rate, and recovers known results, including the Schrödinger equation of Sompolinsky, Crisanti, and Sommers for the largest Lyapunov exponent. As a byproduct, the theory establishes analytically that the chaos is extensive, i.e., the attractor dimension and the entropy rate grow in proportion to N. I had assumed that this problem was analytically intractable. After working independently for 100 minutes with Max thinking, GPT-6 Astra produced the initial derivation, yielding a self-consistent problem whose solution matched simulations of large networks. I found this derivation intriguing, albeit complicated and somewhat mysterious (see AI Methodology in the paper). After investigating the structure of the proposed solution more deeply, together with AI models, I arrived at a physically transparent derivation. I am excited to apply this approach to other network models, trained networks, and, more broadly, to high-dimensional systems to which Lyapunov analysis is relevant, including AI models themselves. Of course, as with any paper, I took care to write up the paper clearly. A few broader thoughts... Neural circuits are high-dimensional nonlinear dynamical systems, and such systems are notoriously hard to understand. I would frame the central problem of theoretical neuroscience as understanding how such systems function, process information, learn, and generate behavior. Many people in the theoretical sciences are anxious about AI. However, in my field at least, we are nowhere close to fully understanding the high-dimensional computations unfolding in our brains. With AI, we could reach a level of understanding that so far we have only gestured toward. So, I am excited.
75
242
47
1,841
199,821
Barney Pell retweeted
Samsung open-sourced a method that shrinks 13B parameter LLM into less than 1 GB. It's called "LittleBit" Instead of storing AI weights as standard numbers, they used latent factorization to crush them down to extreme sub-1-bit levels. In some configurations, they hit 0.1 bits per weight. But here is where the architecture gets crazy. When you compress an AI this much, you can stop doing math. Instead of forcing the hardware to do heavy floating-point multiplication, LittleBit replaces the core computation with a bitwise XOR operation. It swaps complex matrix math for basic sign flips. The results rewrite the rules of model deployment: • Unlocks a massive 11.6x inference speedup relative to standard FP16 models. • Radically reduces memory footprint and loading bandwidth. • Maintains robustness in extreme sub-0.5 bit regimes where previous compression methods catastrophically fail. This is not a clever optimization. It is the blueprint for running massive, state-of-the-art AI locally on cheap, resource-constrained devices.
160
609
132
4,662
231,846
Barney Pell retweeted
🚨 GOOGLE JUST GAVE NOTEBOOKLM A MAJOR UPGRADE. And it’s way more than a simple rebrand. Gemini Notebook is being integrated deeper into Google’s ecosystem, bringing a secure cloud computer and more powerful AI workflows. Yet most people will still use it as nothing more than a PDF summarizer. Here are 8 powerful prompts to turn it into a serious AI research assistant. 🧵
33
87
1
289
19,148
JUST IN: SpaceX’s Transporter-18 mission quietly put several of the core technologies needed for orbital AI data centers into space at the same time. The mission carried three separate experiments targeting the biggest bottlenecks: 1) $GOOGL Google’s Project Suncatcher is testing four custom TPUs in orbit to see how AI hardware handles radiation, heat and spaceflight. 2) Star Catcher’s Protostar (pictured) will attempt to wirelessly beam power between two free-flying spacecraft, potentially allowing future satellites to buy electricity in orbit instead of carrying all of their own generation capacity. 3) Cowboy Space’s Reason-1 will attempt to beam solar energy from orbit back to Earth using an infrared laser, technology the company also plans to use for high-speed links between future orbital data centers. All three launched yesterday aboard $SPCX SpaceX’s Transporter-18 rideshare. The orbital data center race is accelerating as companies test the power and connectivity needed to make large-scale computing in space viable.
18
127
24
771
33,910
Barney Pell retweeted
WOW! Gemini 4 Argon just reached #1 on Blueprint-Bench 2, a benchmark that measures AI’s understanding of the physical 3D world. It is now almost at human-level performance, which is absolutely astonishing considering that just a year ago, AI models were scoring close to zero! In fact, I believe this is one of the most critically important benchmarks for advancing to superintelligence. Understanding the physical 3D world is foundational to interacting with it, making spatial intelligence essential for both robotics AND biology! Most people probably don’t immediately recognize the implications for biology. Yet biological systems operate in 3D space and evolve over time, making them fundamentally 4D, with temporal dimension. Everything in biology depends on spatial organization and dynamic interactions: proteins folding and interacting, cells communicating, immune cells navigating complex tissues, and entire organs functioning as highly coordinated, dynamic systems. Imagine AI models with advanced spatial intelligence combined with a deep understanding of biological mechanisms. Such systems could dramatically accelerate the development of virtual cells, patient digital twins, autonomous scientific laboratories, and ultimately, simulations of entire human organisms. This brings us closer to the ultimate dream: curing all diseases and reversing aging! What makes this so exciting is that AI is advancing toward superintelligence with the potential to understand, model, simulate, and eventually manipulate both the physical and biological worlds. This may be one of the final bosses on the road to scientific superintelligence: AI that understands the world deeply enough to make groundbreaking scientific discoveries, design entirely new biological systems, and transform our ability to engineer life itself!
Is Google so back? Their new Gemini 4 Argon understands the physical 3D world better than any other AI. It ranks #1 on Blueprint-Bench 2, a benchmark where AI agents draw floorplans from photographs of apartment interiors.
14
22
3
318
18,840
Barney Pell retweeted
How ARPA-H is planning to cut clinical trial times from 10+ years to <4 years: 1. 'Phaseless' clinical trials - move towards replacing phase 1 → 2 → 3 with adaptive trials that can cut failed drugs (or advance good ones) faster. 2. Simulate trial outcomes before starting, with digital twins - to reduce reliance on large control groups. 3. AI agents for trial operations. 4. Turn ordinary hospitals into reusable clinical trial sites, and gets AIs to flag eligible trials to doctors and patients.
20
76
10
489
51,386